WithdrawnPhase 4

Comparison Trial for Chloraprep Versus Aqueous Chlorhexidine (2%) for the Prevention of Catheter-related Bacteremia

Stopped: Administrative issues

0Started 2019-10-01

Plain-language summary

A multicentre, open-label clinical trial of two groups comparing cutaneous asepsis with chlorhexidine gluconate at 2% + isopropyl alcohol 70% in relation to the placement of central venous catheters (Study group) with standard asepsis with aqueous chlorhexidine at 2% (Group Control). The incidence of catheter related bacteremia, the incidence of colonization of the skin and the incidence of colonization of the central venous catheter will be evaluated.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients admitted to the ICU. * Patients with age greater than or equal to 18 years. * Patients who require at least one central venous catheters during 48h or more. * Obtaining informed consent. Exclusion Criteria: * Intolerance or known allergy to chlorhexidine, isopropyl alcohol or orange yellow S (E110). * High probability of death within 48 hours after admission. * Use of coated catheter. * Previously included in the study.

What they're measuring

Incidence of catheter-related bacteremia

Timeframe: Up to 48 hours after discharge from the ICU.

Trial details

NCT IDNCT03489512

SponsorInstituto de Investigacion Sanitaria La Fe

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-10-01

View on ClinicalTrials.gov More Sepsis Affecting Skin trials